Ben Tre Pharmaceutical JSC (HOSE: DBT)
Vietnam
· Delayed Price · Currency is VND 12,000
-200 (-1.64%)
At close: Dec 19, 2024
HOSE: DBT Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 18, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
| Market Capitalization | 240,230 | 160,993 | 162,983 | 215,515 | 139,906 | 157,848 | Upgrade
|
| Market Cap Growth | -13.67% | -1.22% | -24.38% | 54.04% | -11.37% | 4.88% | Upgrade
|
| Enterprise Value | 460,413 | 394,589 | 347,380 | 430,214 | 288,233 | 327,666 | Upgrade
|
| Last Close Price | 12250.00 | 8569.12 | 7968.43 | 8980.34 | 8364.21 | 6872.18 | Upgrade
|
| PE Ratio | 12.92 | 7.52 | 8.07 | 7.50 | 5.91 | 7.11 | Upgrade
|
| PS Ratio | 0.26 | 0.20 | 0.20 | 0.27 | 0.24 | 0.29 | Upgrade
|
| PB Ratio | 1.16 | 0.68 | 0.68 | 0.86 | 0.88 | 1.39 | Upgrade
|
| P/TBV Ratio | 0.78 | 0.93 | 1.02 | 1.28 | 1.17 | 1.45 | Upgrade
|
| P/FCF Ratio | - | - | - | 5.12 | 4.96 | - | Upgrade
|
| P/OCF Ratio | - | - | - | 4.22 | 4.28 | - | Upgrade
|
| EV/Sales Ratio | 0.56 | 0.49 | 0.43 | 0.54 | 0.50 | 0.59 | Upgrade
|
| EV/EBITDA Ratio | 10.79 | 9.19 | 8.62 | 10.03 | 7.72 | 43.06 | Upgrade
|
| EV/EBIT Ratio | 15.53 | 13.32 | 12.73 | 13.83 | 8.79 | 87.37 | Upgrade
|
| EV/FCF Ratio | - | - | - | 10.23 | 10.22 | - | Upgrade
|
| Debt / Equity Ratio | 1.56 | 1.37 | 0.92 | 0.88 | 1.24 | 1.69 | Upgrade
|
| Debt / EBITDA Ratio | 8.93 | 7.60 | 5.49 | 5.13 | 5.28 | 25.22 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 5.23 | 6.99 | - | Upgrade
|
| Asset Turnover | 1.23 | 1.22 | 1.31 | 1.39 | 1.19 | 1.46 | Upgrade
|
| Inventory Turnover | 2.51 | 2.71 | 3.55 | 3.42 | 2.47 | 2.42 | Upgrade
|
| Quick Ratio | 0.49 | 0.50 | 0.69 | 0.71 | 0.54 | 0.45 | Upgrade
|
| Current Ratio | 1.19 | 1.17 | 1.18 | 1.23 | 1.03 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 8.48% | 10.11% | 8.75% | 13.79% | 17.59% | 21.49% | Upgrade
|
| Return on Assets (ROA) | 2.75% | 2.81% | 2.76% | 3.38% | 4.22% | 0.62% | Upgrade
|
| Return on Capital (ROIC) | 3.38% | 3.61% | 3.66% | 4.70% | 6.19% | 0.89% | Upgrade
|
| Earnings Yield | 7.74% | 13.29% | 12.39% | 13.33% | 16.91% | 14.07% | Upgrade
|
| FCF Yield | -33.69% | -50.28% | -13.09% | 19.51% | 20.16% | -38.90% | Upgrade
|
| Payout Ratio | 24.72% | 63.23% | 90.84% | 42.72% | 32.46% | 31.52% | Upgrade
|
| Buyback Yield / Dilution | - | - | -30.49% | -10.76% | 4.10% | Upgrade
| |
| Total Shareholder Return | - | - | -30.49% | -10.76% | 4.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.